Americans spend billions annually on prescription medications, making drug costs one of the top healthcare concerns for families and seniors. The federal government offers multiple programs and policies designed to reduce what you pay out-of-pocket for medications. Understanding these options can help you find affordable prescriptions and navigate the complex landscape of drug pricing and assistance.
Federal Drug Pricing Initiatives
The federal government uses several strategies to lower prescription drug prices. Most-favored-nation pricing policies aim to prevent Americans from paying more than patients in other developed countries. One major initiative is TrumpRx, which aims to provide lower-cost prescription options to American patients through government-negotiated agreements with pharmaceutical manufacturers.
Medicare Part D and Negotiated Drug Prices
Medicare Part D provides prescription drug coverage to millions of seniors and beneficiaries with disabilities. In 2026, the program includes significant changes: the annual out-of-pocket spending limit is $2,100, and 10 brand-name drugs with no generic alternatives are now available at negotiated lower prices. These medications treat conditions like heart disease, diabetes, cancer, and autoimmune disorders—with negotiated prices representing at least 38% off 2023 list prices.
Additional Assistance Programs
Beyond Medicare, multiple assistance options exist. The Extra Help program helps eligible individuals pay for Part D premiums, deductibles, and copayments based on income. Many states operate State Pharmaceutical Assistance Programs that coordinate with Medicare to help cover prescription drug costs. The Medicare Prescription Payment Plan allows eligible Part D enrollees to spread costs into monthly installments.
The discounts look dramatic. But here's what the White House doesn't emphasize: for most people with insurance, using the program…
Pharmaceutical manufacturers announced price increases on at least 350 branded medications for 2026, including vaccines against COVID, RSV, and shingles.…
"Most Favored Nation" has long been a cornerstone of international trade policy. It's a principle designed to ensure fairness and…
TrumpRx is a federal government initiative centered around a new website, TrumpRx.gov, slated to launch in early 2026. The primary…